SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (1441)1/19/1998 12:07:00 AM
From: Scott  Read Replies (1) of 1762
 
Maurice, I'm sure that many readers of this thread will have you, your son, and your family in our thoughts and prayers. I hope some of the readers who have expertise in the matter of obtaining drug for offlabel use, and getting reimbursement, will share their expertise. I will certainly be tapping into my network for ideas.

One suggestion: If you have not already done this, try giving Idec's customer service and investor relations people a call. And drop a line to the president, Bill Rastetter. The whole company is made up of very decent people, who appear to really care about meeting the medical needs of their patient constituencies, and I would bet that you would get some inside people who would try to help you find a way to get your son Rituxan, if that is appropriate for his specific NHL. Please let us know what happens, both with your son and with Idec's responsiveness.
- Scott (about to go kiss my 2 sleeping little ones and count my blessings.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext